Tumor-specific deposition of immunoglobulin g and complement in papillary thyroid carcinoma

Human Pathology

Volumn 27, Issue 12, 1996, Pages 1329-1335

  Lucas, Steven D ^a,b   Karlsson Parra, Alex ^a   Nilsson, Bo ^a   Grimelius, Lars ^a   Akerström, Göran ^a   Rastad, Jonas ^a   Juhlin, Claes ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

classical complement pathway; immunoglobulin G; papillary thyroid carcinoma; thyroid diseases; tumor antigens

Indexed keywords

COMPLEMENT COMPONENT C3D; COMPLEMENT COMPONENT C4D; IMMUNOGLOBULIN G; THYROTROPIN RECEPTOR; TUMOR ANTIGEN;

ADULT; AGED; ARTICLE; AUTOIMMUNITY; COMPLEMENT ACTIVATION; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; THYROID CARCINOMA;

EID: 0029829738     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(96)90346-9     Document Type: Article

References (44)

1. Ain KB: Biology and management of differentiated thyroid carcinoma of the follicular cells. In Robbins J (moderator). Thyroid cancer: A lethal endocrine neoplasm. Ann Intern Med 115:133-147, 1991
2. Simpson WJ, McKinney SE, Carruthers JS, et al: Papillary and follicular thyroid cancer: Prognostic factors in 1578 patients. Am J Med 83:479-488, 1987
3. Schelfhout L, Creutzberg C, Hamming J, et al: Multivariate analysis of survival in differentiated thyroid cancer. The prognostic significance of the age factor. Eur J Cancer Clin Oncol 24:331-337, 1988
4. Salvesen H, Njølstad P, Akslen L, et al: Papillary thyroid carcinoma: A multivariate analysis of prognostic factors including an evaluation of the p-TNM staging system. Eur J Surg 158:583-589, 1992
5. Samaan NA, Schultz PN, Hickey RC, et al: The results of various modalities of treatment of well differentiated thyroid carcinoma: A retrospective review of 1599 patients. J Clin Endocrinol Metab 75:714-720, 1992
6. Daily M, Lindsay S, Skahen R: Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland. Arch Surg 70:291-297, 1955
7. Hirabayashi RN, Lindsay S: The relation of thyroid carcinoma and chronic thyroiditis. Surg Gyn Obstet 121:243-252, 1965
8. Kamma H, Fujii K, Ogata T: Lymphocytic infiltration in juvenile thyroid carcinoma. Cancer 62:1988-1993, 1988
9. Schilcke C, Hill J, Schultz G: Carcinoma in chronic thyroiditis. Surg Gynecol Obstet 111:552-556, 1960
10. Hedinger C: Histological Typing of Thyroid Tumours (ed 2). New York, NY, Springer-Verlag, 1988
11. Van Noorden S: Tissue prepatation and immunostaining techniques for light microscopy, Polak J, Van Noorden S (ed): Immunocytochemistry: Modern Methods and Applications (ed 2). London, Wright, 1985, pp 26-53
12. Johannesson J, Sobrinho-Simoes M: The origin and significance of psammoma bodies. Lab Invest 43:287-296, 1980
13. Klinck G, Winship T: Psammoma bodies and thyroid cancer. Cancer 12:656-662, 1959
14. Tanimoto C, Hirakawa S, Kawasaki H, et al: Apoptosis in thyroid diseases: A histochemical study. Endocr J 42:193-201, 1995
15. Jefferis R, Reimer C, Skvaril F, et al: Evaluation of monoclonal antibodies having specificity for human IgG sub-classes: Results of an IUIS/WHO collaborative study. Immunol Lett 10:223-252, 1985
16. Jefferis R, Reimer C, Skvaril F, et al: Evaluation of monoclonal antibodies having specificity for human IgG subclasses: Results of the 2nd IUIS/WHO collaborative study. Immunol Lett 31:143-168, 1992
17. Kinoshita T: Biology of complement: The overture. Immunol Today 12:291-295, 1991
18. Isturiz M, Geffner J, Pizzolato M: Two different fc gamma receptor-dependent cytotoxic mechanisms triggered by monoclonal immunoglobulins. Immunol Lett 29:271-275, 1991
19. Canfield S, Morrison S: The binding affinity of human IgG for its high affinity fc receptor is determined by multiple amino acids in the ch2 domain and is modulated by the hinge region. J Exp Med 173:1483-1491, 1991
20. . Hamada S, Furumoto H, Kamada M, et al: High expression rate of Tn antigen in metastatic lesions of uterine cervical cancers. Cancer Lett 74:167-173, 1993
21. Misevic GN, Popescu O: A novel class of embryonic cell adhesion glycan epitopes is expressed in human colon carcinomas. J Mol Recog 8:100-5, 1995
22. Yamashita Y, Chung Y, Horie R, et al: Alterations in gastric mucin with malignant transformation: Novel pathway for mucin synthesis. J Natl Cancer Inst 87:441-446, 1995
23. Yoshimura M, Nishikawa A, Ihara Y, et al: Suppression of lung metastasis of B16 mouse melanoma by N-acetylglucosaminyltransferase III gene transfection. Proc Natl Acad Sci U S A 92:8754-8758, 1995
24. Ho JJ, Siddiki B, Kim YS: Association of sialyl-Lewis (a) and sialyl-Lewis(x) with MUC-1 apomucin ina pancreatic cancer cell line. Cancer Res 55:3659-3663, 1995
25. Nahm M, Scott M, Shackelford P: Expression of human IgG subclasses. Ann Clin Lab Sci 17:183-196, 1987
26. Barrett D, Ayoub E: IgG2 subclass restriction of antibody to pneumococcal polysaccharides. Clin Exp Immunol 63:127-134, 1986
27. Weetman A, Byfield P, Black C, et al: IgG heavy-chain subclass restriction of thyrotropin-binding inhibitory immunoglobulins in Graves' disease. Eur J Clin Invest 20:406-410, 1990
28. McLachlan S, Feldt-Rasmussen U, Young E, et al: IgG subclass distribution of thyroid autoantibodies: A fingerprint of an individual's response to thyroglobulin and thyroid microsomal antigen. Clin Endocrinol (Oxf) 26:335-346, 1987
29. Davies T, Weber C, Wallack P, et al: Restricted heterogeneity and T cell dependence of human thyroid autoantibody immunoglobulin G subclasses. J Clin Endocrinol Metab 62:945-949, 1986
30. Nakai H, Hirakawa N, Amano T, et al: Enhanced expression of complement regulatory proteins on thyroid cells of Graves' disease. Acta Med Okayama 46:323-330, 1992
31. Yamakawa M, Yamada K, Tsuge T, et al: Protection of thyroid cancer cells by complement regulatory factors. Cancer 73:2808-2817, 1994
32. Denton G, Durrant L, Hardcastle J, et al: Clinical outcome of colorectal cancer patients treated with human monoclonal antiidiotypic antibody. Int J Cancer 57:10-14, 1994
33. Stull S, Sharp G, Kyriakos M, et al: Induction of granulomaus experimental autoimmune thyroiditis in mice with in vitro activated effector T cells and anti-IFN-γ antibody. J Immunol 149:2219-2226, 1992
34. Weetman A: Autoimmunity to steroid-producing cells and familial polyendocrine autoimmunity. Baillieres Clin Endocrinol Metab 9:157-174, 1995
35. Mittelman A, Chen Z, Liu C, et al: Kinetics of the immune response and regression of metastatic lesions following development of humoral anti-high molecular weight-melanoma associated antigen immunity in three patients with advanced malignant melanoma immunized with mouse antiidiotypic monoclonal antibody MK2-23. Cancer Res 54:415-421, 1994
36. Fagerberg J, Steinitz M, Wigzell H, et al: Human anti-idiotypic antibodies induced a humoral and cellular immune response against a colorectal carcinoma-associated antigen in patients. Proc Natl Acad Sci U S A 92:4773-4777, 1995
37. Morton D, Foshag L, Hoon D, et al: Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine. Arch Surg 216:463-482, 1992
38. Samonigg H, Wilders-Trunschnig M, Loibner H, et al: Immune response to tumor antigens in a patient with colorectal cancer after immunization with anti-idiotype antibody. Clin Immunol Immunopathol 65:271-277, 1992
39. Pan ZK, Ikonomidis G, Lazenby A, et al: A recombinant Listeria monocytogenes vaccine expressing a model tumor antigen protects mice against lethal tumour challenge and causes regression of established tumours. Nature Med 1:471-477, 1995
40. Falo LD, Kovacsovics-Bankowski M, Thompson K, et al: Targeting antigen into the phagocytic pathway in vivo induces protective tumor immunity. Nature Med 1:649-653, 1995
41. Pullyblank A, Guillou P, Monson J: m17-1A-, c17-1A- and cSF25-mediated antibody-dependent cell-mediated cytotoxicity in patients with advanced cancer. Br J Cancer 70:753-758, 1994
42. Hellstrom I, Garrigues U, Lavie E, et al: Antibody-mediated killing of human tumor cells by attached effector cells. Cancer Res 48:624-627, 1988
43. Ortaldo JR, Woodhouse C, Morgan AC, et al: Analysis of effector cells in human antibody-dependent cellular cytotoxicity with murine monoclonal antibodies. J Immunol 138:3566-3572, 1987
44. Graziano RF, Fanger MW: Cytotoxicity mediated by human Fc receptors for IgG. Immunol Today 10:92-99, 1989